Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Full-Time Occlusion Therapy for Intermittent Exotropia in Children

NCT: NCT05462821 · COMPLETED

NCT IDNCT05462821
StatusCOMPLETED
Start Date2022-11-01
Completion2025-05-01
SponsorJaeb Center for Health Research (OTHER)
First posted
Last updated

Brief Summary

Determine whether full-time patching is more effective than observation for improving distance control of IXT after 3 months of treatment (on-treatment outcome).

Frequently Asked Questions

What is Full-Time Occlusion Therapy for Intermittent Exotropia in Children?

Full-Time Occlusion Therapy for Intermittent Exotropia in Children is a clinical trial registered under NCT05462821. Current status: COMPLETED.

What is the status of NCT05462821?

The current status of NCT05462821 (Full-Time Occlusion Therapy for Intermittent Exotropia in Children) is: COMPLETED.

When did Full-Time Occlusion Therapy for Intermittent Exotropia in Children start?

Full-Time Occlusion Therapy for Intermittent Exotropia in Children started on 2022-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.